Glykrez Total 30 Tablet SR
Marketer
Krezlin Pharma
Salt Composition
Gliclazide (30mg) + Pioglitazone (15mg) + Metformin (500mg)
Overview Glykrez Total 30 Tablet SR
Diabetic patients with type 2 diabetes mellitus may find relief with the extended-release Glykrez Total 30 Tablet. This medication effectively manages blood glucose levels in adults. Optimal efficacy is achieved by taking this medication with food, consistently at the same time daily, as prescribed by your physician. Dosage adjustments may occur based on your blood sugar monitoring. Discontinuing this medicine without consulting your doctor is strongly discouraged; abrupt cessation can elevate blood sugar, potentially leading to complications such as nephropathy, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle modifications are critical to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms such as sweating, dizziness, and headache. Prompt treatment with fast-acting glucose, like sugary snacks or fruit juice, is crucial. Maintain regular meal times and always carry a glucose source. Alcohol consumption should be avoided due to its potential to exacerbate hypoglycemia. Additional potential side effects include nausea, altered taste perception, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should disclose this information to their physician before commencing treatment. Pregnant or lactating women should consult their doctor. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, will be necessary.
Uses of Glykrez Total 30 Tablet SR
Managing type 2 diabetes
Major Benefits of Glykrez Total 30 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glykrez Total 30 Tablet SR should be administered with a meal.
Common Side effects of Glykrez Total 30 Tablet SR:
- Hypoglycemia (low blood glucose level)
- Dizziness
- Headache
- Nausea
- Vomiting
- Diarrhea
- Flatulence
- Upper respiratory tract infection
- Bronchitis (inflammation of the airways)
- Anemia (low number of red blood cells)
- Edema (swelling)
How to use Glykrez Total 30 Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Glykrez Total 30 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Glykrez Total 30 Tablet SR works:
Glykrez Total 30 SR tablets contain a triple-action formula addressing type 2 diabetes. This formulation combines gliclazide (a sulfonylurea), pioglitazone (a thiazolidinedione), and metformin (a biguanide), each acting via distinct pathways to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Gliclazide stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Pioglitazone enhances insulin sensitivity. Metformin reduces hepatic glucose production, slows intestinal glucose absorption, and improves insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glykrez Total 30 Tablet SR and alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Glykrez Total 30 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glykrez Total 30 Tablet may pose a risk to breastfeeding infants. Available evidence indicates potential transfer to breast milk with the possibility of infant harm.
DrivingCAUTION
Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
Patients with kidney disease should likely avoid Glykrez Total 30 Tablet SR; its use is potentially unsafe. A physician's consultation is recommended.
LiverUNSAFE
Patients with liver conditions should likely avoid Glykrez Total 30 Tablet SR; its use is potentially unsafe. A physician's advice is recommended.
What if you forget to take Glykrez Total 30 Tablet SR :
Should you forget a Glykrez Total 30 Tablet SR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glykrez Total 30 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |



